Photo of Mary-Ellen Meadows,  PhD

Mary-Ellen Meadows, PhD

Brigham And Women's Hospital

Brigham And Women's Hospital
Phone: (617) 732-8060
Fax: (617) 738-9122


mmeadows@partners.org

Mary-Ellen Meadows, PhD

Brigham And Women's Hospital

EDUCATIONAL TITLES

  • Assistant Professor, Psychiatry, Harvard Medical School
  • Neuropsychologist, Neurology, Brigham And Women's Hospital

Research Abstract

I have been interested in the cognitive outcomes in adult survivors of childhood cancer. In particular, I am studying individuals who were treated for leukemia as children or adolescents. I have primarily focused on neuropsychological measures in this particular study. I am also involved in a study assessing cognitive outcomes in adults who have been treated with chemotherapy and bone marrow transplants for treatment of CML. We have been following individuals prospectively with psychological questionnaires and neuropsychological measures.

Publications

Powered by Harvard Catalyst
  • Chang G, Meadows ME, Smallwood JA, Antin JH, Orav EJ. Cognitive and Other Predictors of Change in Quality of Life One-Year After Treatment for Chronic Myelogenous Leukemia or Myelodysplastic Syndrome. J Neuropsychiatry Clin Neurosci 2014. PubMed
  • Meadows ME, Chang G, Jones JA, Antin JR, Orav EJ. Predictors of Neuropsychological Change in Patients with Chronic Myelogenous Leukemia and Myelodysplastic Syndrome. Arch Clin Neuropsychol 2013. PubMed
  • Chang G, Meadows ME, Jones JA, Antin JH, Orav EJ. Substance use and survival after treatment for chronic myelogenous leukemia (CML) or myelodysplastic syndrome (MDS). Am J Drug Alcohol Abuse 2010; 36:1-6. PubMed
  • Chang G, Meadows ME, Orav EJ, Antin JH. Mental status changes after hematopoietic stem cell transplantation. Cancer 2009; 115:4625-35. PubMed